[{"Assets_0_Q3_USD":524626000.0,"CommonStockSharesOutstanding_0_Q3_shares":39863711.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-7024000.0,"NetIncomeLoss_1_Q3_USD":-24559000.0,"NetIncomeLoss_3_Q3_USD":-133184000.0,"StockholdersEquity_0_Q3_USD":339650000.0,"Ticker":"PRTA","CIK":"1559053","name":"PROTHENA CORP PLC","OfficialName":"Prothena Corporation plc Ordinary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1633142175.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]